Obesity Clinical Trial
— TASTYOfficial title:
Efficacy of Medical Nutrition Therapy of Obese Patients Supported by Hypnotic Suggestions or Telemedicine
Verified date | May 2020 |
Source | Warsaw University of Life Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is the assessment of the effectiveness of medical nutrition therapy
(MNT) among obese patients, including a well-balanced low-calories diet, an individual
dietary counseling conducted by dietitians and supported by telemedicine (T) or hypnotic
suggestions (HS).
The study will cover a group of 90 adult patients, both sexes, with obesity (BMI ≥30 kg/m^2)
undergoing MNT a dietetic treatment. Three arms are planned in the study scheme, according to
the scheme: Group 1 - individual MNT (30 people); Group 2 -individual MNT and T (30 people);
Group 3 - individual MNT and HS (30 people).
The authors hope that the results of the study will allow to develop a new model of the most
effective management of obesity, resulting in weight reduction and maintaining this effect
over time. The results obtained during the study will also allow to assess the impact of the
therapy applied on lifestyle changes, dietary habits and the knowledge about the disease
among obese patients.
Status | Completed |
Enrollment | 90 |
Est. completion date | December 10, 2019 |
Est. primary completion date | June 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Subject is over 18 years. - Subject is diagnosed with obesity (BMI = 30 kg / m^2 at the screening visit). - Subject understands the study procedures and is able to give written informed consent. Exclusion Criteria: - Subject is under 18 years. - Subject is a pregnant women or a breast-feeding mother; or subject is planning to be pregnant during the study period - Subject is suffering from chronic liver diseases or renal failure - Subject has untreated or uncompensated thyroid diseases - Subject has a history of presence of mental disorders - Subject has a history of presence of epilepsy - Subject has a history of presence of cancer - Any other uncontrolled physical or psychological condition that increases significantly the health risks for the subject |
Country | Name | City | State |
---|---|---|---|
Poland | Faculty of Human Nutrition and Consumer Sciences of the Warsaw University of Life Sciences | Warsaw |
Lead Sponsor | Collaborator |
---|---|
Warsaw University of Life Sciences |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Arterial stiffness | Arterial stiffness measurement using an applanation tonometer (Sphygmocor, AtCor Medical, Sydney, Australia | baseline, month 12 | |
Other | Resting Metabolic Rate | Resting Metabolic Rate measurement using FitMate metabolic system (Cosmed, Rome, Italy) | baseline, month 12 | |
Other | Nutritional knowledge score baseline | Nutritional knowledge measurement using Nutritional Knowledge 13-items Test | baseline, month 6 | |
Other | The patient's readiness for making changes | The patient's readiness for making changes assessed by a questionnaire (Intrinsic Motivation Inventory, IMI-SR Motivation Questionnaire) and the scale of perception of own competences | baseline | |
Primary | Body Weight | Changes in body weight from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 12 months for Part B) | 6 months (Part A); up to 12 months (Part B) | |
Primary | Body Mass Index | Changes in BMI from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 12 months for Part B) | 6 months (Part A); up to 12 months (Part B) | |
Secondary | Waist circumference | Changes in waist circumference from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 12 months for Part B) | 6 months (Part A); up to 12 months (Part B) | |
Secondary | Hip circumference | Changes in hip circumference from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 12 months for Part B) | up to 6 months (Part A); up to 12 months (Part B) | |
Secondary | Arm circumference | Changes in arm circumference from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 12 months for Part B) | 6 months (Part A); up to 12 months (Part B) | |
Secondary | Body composition | Changes in body fat mass, fat free mass, muscle mass using bioelectrical impedance analysis from baseline (month 0) to each post-randomization visit (month 1, 3, 6 for Parts A and 9, 18 months for Part B) | 6 months (Part A); up to 12 months (Part B) | |
Secondary | Health related quality of life | Changes in Health related quality of life using the EQ-5D-5L questionnaire | baseline, month 6, 9, 12 | |
Secondary | Dietary intake | Changes in dietary intakes using 4-day recorded diet diaries from baseline (month 0) to each post-randomization visit | 6 months (Part A); up to 12 months (Part B) | |
Secondary | Sleep behaviour | Sleep behaviour using Athens Insomnia Scale (AIS) | baseline and month 6 for Parts A and month 12 for Part B | |
Secondary | Subjective assessment of health status | Changes in subjective assessment of health status using 5-points Likert-type rating scale | baseline and month 6 for Parts A and month 12 for Part B |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |